Cargando…
Treatment-Resistant Depression Entering Remission Following a Seizure during the Course of Repetitive Transcranial Magnetic Stimulation
Major depressive disorder is often resistant to antidepressant treatment. Repetitive transcranial magnetic stimulation (rTMS) has been used in treatment-resistant depression (TRD). Known adverse events of rTMS include transient headache, local pain, syncope, seizure induction, and hypomania inductio...
Autores principales: | Kim, Ju-Wan, Bae, Kyung-Yeol, Kim, Sung-Wan, Kang, Hee-Ju, Shin, Il-Seon, Yoon, Jin-Sang, Kim, Jae-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Neuropsychiatric Association
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965659/ https://www.ncbi.nlm.nih.gov/pubmed/27482250 http://dx.doi.org/10.4306/pi.2016.13.4.468 |
Ejemplares similares
-
Predictors of Remission in Acute and Continuation Treatment of Depressive Disorders
por: Kim, Ha-Yeon, et al.
Publicado: (2021) -
Time to remission analysis for major depressive disorder after repetitive transcranial magnetic stimulation (rTMS)
por: Manzardo, Ann M., et al.
Publicado: (2019) -
Prediction of 12-Week Remission by Psychopharmacological Treatment Step in Patients With Depressive Disorders
por: Jin, Yun-Tae, et al.
Publicado: (2022) -
Thyroid Stimulating Hormone, Cognitive Impairment and Depression in an Older Korean Population
por: Kim, Jae-Min, et al.
Publicado: (2010) -
Comorbidity of Depression with Physical Disorders: Research and Clinical Implications
por: Kang, Hee-Ju, et al.
Publicado: (2015)